Remote Evaluation of MIND Diet
Recruiting · NCT06450977 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Illinois at Urbana-Champaign
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The goal of this clinical trial is to learn if increasing adherence to a Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet pattern improves thinking ability and memory compared to a healthy control diet in persons with Multiple Sclerosis (MS). The main question it aims to answer is: Does the MIND diet improve cognitive performance relative to a control diet in persons with MS? Participants will: Consume one meal that follows the MIND diet or a control meal every day for 3 months, complete online surveys and cognitive testing before and after, and keep a record of the food they eat during the study.
Who can take part
Inclusion criteria
- Individuals aged 18-64 years old
- Self-reported diagnosis of Multiple sclerosis (MS)
- 20/20 or corrected vision
- No other neurodegenerative disease diagnosis
- Stable disease-modifying therapy (DMT) within 6 months
- Not Pregnant or lactating
- No food allergies or intolerances
- Able to consume study meals
- Not enrolled in another dietary, exercise, or medication study during the study
- Access to a computer/laptop with internet
Exclusion criteria
- Individuals younger than 18 or older than 64 years old
- No self-reported diagnosis of Multiple sclerosis (MS)
- Not 20/20 or uncorrected vision
- Other neurodegenerative disease diagnosis
- Disease modifying therapy (DMT) less than 6 months
- Pregnant or lactating
- Food allergies or intolerances
- Not able to consume study meals
- Enrolled in another dietary, exercise, or medication study during the study
- No access to a computer/laptop with internet
Where it is running
1 location listed across 1 US state.
- University of Illinois Urbana-Champaign - Urbana, Illinois, United States